Evaluation of a 2-minute anti-human immunodeficiency virus (HIV) test using the autologous erythrocyte agglutination technique with populations differing in HIV prevalence.
A total of 1,800 blood specimens (1,000 from healthy blood donors, 300 from patients with sexually transmitted disease, and 500 from intravenous drug users) were simultaneously tested with anti-human immunodeficiency virus enzyme-linked immunosorbent assay (ELISA) kits and a newly developed 2-min test for anti-human immunodeficiency virus based on the principle of autologous erythrocyte agglutination (AGEN Biomedical Limited). We found that AGEN's rapid test was as sensitive and specific as the other ELISA kits.
Sirivichayakul
S
S
Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Phanuphak
P
P
Tanprasert
S
S
Thanomchat
S
S
Uneklabh
C
C
Phutiprawan
T
T
Mungklavirat
C
C
Panjurai
Y
Y
D015492:AIDS Serodiagnosis / Q000379:methods*; D001782:Blood Donors; D005069:Evaluation Studies as Topic; D015483:HIV Antibodies / Q000097:blood*; D015528:HIV Seroprevalence; D015497:HIV-1 / Q000276:immunology*; D006386:Hemagglutination Tests / Q000379:methods* / Q000706:statistics & numerical data; D006801:Humans; D012680:Sensitivity and Specificity; D012749:Sexually Transmitted Diseases; D015819:Substance Abuse, Intravenous; D013997:Time Factors
D015483:HIV Antibodies